The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis: Sarcopenic obesity and myosteatosis in cirrhosis
Open accessAbstract
BACKGROUND AND AIMS: Obesity is frequently associated with cirrhosis, and cirrhotic patients may develop simultaneous loss of skeletal muscle and gain of adipose tissue, culminating in the condition of sarcopenic obesity. Additionally, muscle depletion is characterized by both a reduction in muscle size and increased proportion of muscular fat, termed myosteatosis. In this study, we aimed to establish the frequency and clinical significance of sarcopenia, sarcopenic obesity and myosteatosis in cirrhotic patients. METHODS: We analysed 678 patients with cirrhosis. Sarcopenia, sarcopenic obesity and myosteatosis were analysed by CT scan using the third lumbar vertebrae skeletal muscle and attenuation indexes, using previously validated gender-and body mass index-specific cutoffs. RESULTS: Patients were predominately men (n = 457, 67%), and cirrhosis aetiology was hepatitis C virus in 269 patients (40%), alcohol in 153 (23%), non-alcoholic steatohepatitis/cryptogenic in 96 (14%), autoimmune liver disease in 55 (8%), hepatitis B virus in 43 (6%), and others in 5 patients (1%). Sarcopenia was present in 292 (43%), 135 had sarcopenic obesity (20%) and 353 had myosteatosis (52%). Patients with sarcopenia (22 ± 3 vs. 95 ± 22 months, P < 0.001), sarcopenic obesity (22 ± 3 vs. 95 ± 22 months, P < 0.001), and myosteatosis (28 ± 5 vs. 95 ± 22 months, P < 0.001) had worse median survival than patients without muscular abnormalities. By multivariate Cox regression analysis, both sarcopenia [hazard ratio (HR) 2.00, 95% confidence interval (CI) 1.44-2.77, P < 0.001], and myosteatosis (HR 1.42, 95% CI 1.02-1.07, P = 0.04) were associated with mortality. CONCLUSIONS: Sarcopenia, sarcopenic obesity and myosteatosis are often present in patients with cirrhosis, and sarcopenia and myosteatosis are independently associated with a higher long-term mortality in cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Obesity and sarcopenic obesity are risk factors for clinical decompensation and worsen prognosis.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [450]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sarcopenic obesity, the state of decreased muscle mass in the setting of increased fat mass, occurs mainly in MASH-related cirrhosis and is found in 20 -35% of individuals with cirrhosis pre-and-post liver transplant.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [450]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global nutrition transition and the pandemic of obesity in developing countries
Popkin, B. M., Adair, L. S., & Ng, S. W. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00456.x · Cited by 4,313
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004
Martin, L., Birdsell, L., Macdonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R. A., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,761
Mourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
Ogden, C. L., Yanovski, S. Z., Carroll, M. D., & Flegal, K. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.052 · Cited by 1,561
Mitsiopoulos, N., Baumgartner, R. N., Heymsfield, S. B., Lyons, W., Gallagher, D., & Ross, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.1.115 · Cited by 1,522
Visser, M., Goodpaster, B. H., Kritchevsky, S. B., Newman, A. B., Nevitt, M., Rubin, S. M., Simonsick, E. M., Harris, T. B., & Study, F. T. H. A. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.3.324 · Cited by 1,403
Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis
Montaño‐Loza, A. J., Meza–Junco, J., Prado, C. M. M., Lieffers, J. R. L., Baracos, V. E., Bain, V. G., & Sawyer, M. B. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.028 · Cited by 827
Sarcopenia: etiology, clinical consequences, intervention, and assessment
Lang, T., Streeper, T., Cawthon, P. M., Baldwin, K., Taaffe, D. R., & Harris, T. B. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1059-y · Cited by 815
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 513
Azevedo, V. Z., Silaghi, C. A., Maurel, T., Silaghi, H., Ratziu, V., & Pais, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.774030 · Cited by 59
Bischoff, S. C., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Eshraghian, A., Kani, H. T., Khannoussi, W., Lacaze, L., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12280 · Cited by 62
Xie, L., Jiang, J., Fu, H., Zhang, W., Yang, L. Y., & Yang, M. J. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.11.025 · Cited by 53
Outcome of liver transplantation in patients with prior bariatric surgery
Safwan, M., Collins, K. M., Abouljoud, M. S., & Salgia, R. J. (2017) · Liver Transplantation · doi:10.1002/lt.24832 · Cited by 53
Traub, J., Bergheim, I., Eibisberger, M., & Stadlbauer, V. (2020) · Nutrients · doi:10.3390/nu12020547 · Cited by 57
Tan, L., Ji, G., Bao, T., Fu, H., Yang, L. Y., & Yang, M. J. (2021) · Insights into Imaging · doi:10.1186/s13244-021-01106-2 · Cited by 53
O’Brien, S. J., Kavanagh, R. G., Carey, B. W., Maher, M. M., O’Connor, O. J., & Andrews, E. J. (2018) · European Radiology Experimental · doi:10.1186/s41747-018-0072-3 · Cited by 54
Role of Nutrition and Muscle in Cirrhosis
Thandassery, R. B., & Montaño‐Loza, A. J. (2016) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-016-0093-z · Cited by 52
Poltronieri, T. S., de Paula, N. S., & Chaves, G. V. (2020) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12629 · Cited by 52
Kunimura, A., Ishii, H., Uetani, T., Aoki, T., Harada, K., Hirayama, K., Negishi, Y., Shibata, Y., Sumi, T., Kawashima, K., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.01.008 · Cited by 50
Sarcopenia – Endocrinological and Neurological Aspects
Stangl, M. K., Böcker, W., Chubanov, V., Ferrari, U., Fischereder, M., Gudermann, T. W., Hesse, E., Meinke, P., Reincke, M., Reisch, N., et al. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0672-1007 · Cited by 56
Czigány, Z., Kramp, W., Lurje, I., Miller, H., Bednarsch, J., Lang, S. A., Ulmer, T. F., Bruners, P., Strnad, P., Trautwein, C., et al. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12669 · Cited by 50
Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease
Tachi, Y., Kozuka, A., Hirai, T., Ishizu, Y., Honda, T., Kuzuya, T., Hayashi, K., Ishigami, M., & Goto, H. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14133 · Cited by 50
Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
Gill, M. G., & Majumdar, A. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i12.1168 · Cited by 51
Models of sarcopenia: Short review
Palus, S., Springer, J., Doehner, W., von Haehling, S., Anker, M. S., Anker, S. D., & Springer, J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.152 · Cited by 48
Moctezuma‐Velázquez, C., Ebadi, M., Bhanji, R. A., Stirnimann, G., Tandon, P., & Montaño‐Loza, A. J. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.11.024 · Cited by 48
Sarcopenic obesity in fatty liver
Merli, M., Lattanzi, B., & Aprile, F. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000558 · Cited by 48
Phase angle as a marker for sarcopenia in cirrhosis
Silva, D. E. S., Waitzberg, D. L., de Jesús, R. P., de Oliveira, L. P. M., Torrinhas, R. S., & Belarmino, G. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.05.003 · Cited by 48
Stam, S. P., Eisenga, M. F., Neto, A. W. G., van Londen, M., de Meijer, V. E., van Beek, A. P., Gansevoort, R. T., & Bakker, S. J. L. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12399 · Cited by 48
Jamali, T., Raasikh, T., Bustamante, G., Sisson, A., Tandon, P., Duarte-Rojo, A., & Hernaez, R. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001883 · Cited by 47
Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
Carneros, D., López‐Lluch, G., & Bustos, M. (2020) · Nutrients · doi:10.3390/nu12113472 · Cited by 48
Shen, Y., Luo, L., Fu, H., Xie, L., Zhang, W., Lü, J., & Yang, M. J. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12948 · Cited by 45
Ha, N. B., Montaño‐Loza, A. J., Carey, E. J., Lin, S., Shui, A. M., Huang, C., Dunn, M. A., & Lai, J. C. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17079 · Cited by 46
Johnston, H. E., Takefala, T. G., Kelly, J. T., Keating, S. E., Coombes, J. S., Macdonald, G. A., Hickman, I. J., & Mayr, H. L. (2022) · Nutrients · doi:10.3390/nu14163365 · Cited by 46
Shafaat, O., Liu, Y., Jackson, K. R., Motter, J. D., Boyarsky, B. J., Latif, M. A., Yuan, F., Khalil, A. A. F., King, E. A., Zaheer, A., et al. (2022) · Radiology · doi:10.1148/radiol.212403 · Cited by 46
Jahangiri, Y., Pathak, P., Tomozawa, Y., Li, L., Schlansky, B. L., & Farsad, K. (2019) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2019.01.005 · Cited by 46
Bariatric surgery and the liver—Mechanisms, benefits, and risks
Lefere, S., Onghena, L., Vanlander, A., Nieuwenhove, Y. V., Devisscher, L., & Geerts, A. M. (2021) · Obesity Reviews · doi:10.1111/obr.13294 · Cited by 49
Nachit, M., Lanthier, N., Rodriguez, J., Neyrinck, A. M., Cani, P. D., Bindels, L. B., Hiel, S., Pachikian, B. D., Tréfois, P., Thissen, J., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100323 · Cited by 48
Bischoff, S. C., Ockenga, J., Eshraghian, A., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Kani, H. T., Khannoussi, W., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.03.021 · Cited by 47
Alalwan, T. A. (2020) · Geriatrics · doi:10.3390/geriatrics5010008 · Cited by 44
Assessment of Acute Pancreatitis Severity and Prognosis with CT-Measured Body Composition
Zhou, Y., Hao, N.-B., Duan, Z., Kong, M., Xu, M., Zhang, D., Xu, X., Yuan, Q., & Li, C. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s322589 · Cited by 42
Kalafateli, M. (2018) · Annals of Gastroenterology · doi:10.20524/aog.2018.0256 · Cited by 43
Hou, L., Deng, Y., Fan, X., Zhao, T., Cui, B., Lin, L., Hou, J., Mao, L., Zhao, W., Jiang, K., et al. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1841 · Cited by 43
Meister, F., Lurje, G., Verhoeven, S., Wiltberger, G. J., Heij, L. R., Liu, W., Jiang, D., Bruners, P., Lang, S. A., Ulmer, T. F., et al. (2022) · Cancers · doi:10.3390/cancers14030720 · Cited by 43
Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD
Linge, J., Nasr, P., Sanyal, A. J., Dahlqvist Leinhard, O., & Ekstedt, M. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2022.100663 · Cited by 42
Perkisas, S., Cock, A. D., Verhoeven, V., & Vandewoude, M. F. J. (2017) · Geriatrics · doi:10.3390/geriatrics2010011 · Cited by 42
Adipopenia correlates with higher portal pressure in patients with cirrhosis
Rodrigues, S. G., Brabandt, B., Stirnimann, G., Maurer, M. H., & Berzigotti, A. (2019) · Liver International · doi:10.1111/liv.14175 · Cited by 41
Vidot, H., Kline, K., Cheng, R., Finegan, L., Lin, A., Kempler, E., Strasser, S. I., Bowen, D. G., McCaughan, G. W., Carey, S., et al. (2019) · Nutrients · doi:10.3390/nu11092097 · Cited by 40
Clarembeau, F., Bale, G., & Lanthier, N. (2020) · Clinical Science · doi:10.1042/cs20200022 · Cited by 40
Hepatic immune regulation and sex disparities
Burra, P., Zanetto, A., Schnabl, B., Reiberger, T., Montaño‐Loza, A. J., Asselta, R., Karlsen, T. H., & Tacke, F. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00974-5 · Cited by 43
Hegyi, P., Soós, A., Hegyi, P., Szakács, Z., Hanák, L., Váncsa, S., Ocskay, K., Pétervári, E., Balaskó, M., Erőss, B. M., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.599434 · Cited by 39
Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis
Ebadi, M., & Montaño‐Loza, A. J. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.05.034 · Cited by 39
Myopenic obesity determined by visceral fat area strongly predicts long-term mortality in cirrhosis
Feng, H., Wang, X., Zhao, T., Mao, L., Hui, Y., Fan, X., Lin, L., Zhao, W., Jiang, K., Wang, B., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.09.016 · Cited by 38
[ESPEN Practical Guideline: Clinical nutrition in liver disease].
Bischoff, S., Bernal, W., Dasarathy, S., Merli, M., Plank, L., Schütz, T., Plauth, M., Peláez, R. B., & Irigoín, R. R. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.03856 · Cited by 17
Influence of tube potential on CT body composition analysis
Morsbach, F., Zhang, Y., Nowik, P., Martin, L., Lindqvist, C., Svensson, A., & Brismar, T. B. (2018) · Nutrition · doi:10.1016/j.nut.2017.12.016 · Cited by 36
Lindqvist, C., Brismar, T. B., Majeed, A., & Wåhlin, S. (2018) · Nutrition · doi:10.1016/j.nut.2018.10.031 · Cited by 38
Nutritional assessment in patients with liver cirrhosis
Ali, S. H., Sneineh, A. T. A., & Hasweh, R. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i9.1694 · Cited by 42
Palmese, F., Bolondi, I., Giannone, F. A., Zaccherini, G., Tufoni, M., Baldassarre, M., & Caraceni, P. (2019) · Nutrients · doi:10.3390/nu11102462 · Cited by 35
Radiologic Definition of Sarcopenia in Chronic Liver Disease
Lee, C., Kang, B.-K., & Kim, M. (2021) · Life · doi:10.3390/life11020086 · Cited by 37
Ebadi, M., Dunichand‐Hoedl, A. R., Rider, E., Kneteman, N. M., Shapiro, A. M. J., Bigam, D. L., Dajani, K. Z., Mazurak, V. C., Baracos, V. E., & Montaño‐Loza, A. J. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100495 · Cited by 38
The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity
Papadopetraki, A., Giannopoulos, A., Maridaki, M., Zagouri, F., Droufakou, S., Koutsilieris, M., & Philippou, A. (2023) · Cancers · doi:10.3390/cancers15245856 · Cited by 34
Nardelli, S., Gioia, S., Faccioli, J., Riggio, O., & Ridola, L. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i35.5257 · Cited by 34
Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients
Aby, E. S., & Saab, S. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.06.001 · Cited by 33
Román, E. M., Poca, M., Amorós-Figueras, G., Rosell, J., Gely, C., Nieto, J. C., Vidal, S., Urgell, E., Ferrero‐Gregori, A., Alvarado‐Tápias, E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99199-8 · Cited by 33
Impact of sarcopenic overweight on the outcomes after living donor liver transplantation
Hammad, A., Kaido, T., Hamaguchi, Y., Okumura, S., Kobayashi, A., Shirai, H., Kamo, N., Yagi, S., & Üemoto, S. (2017) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2017.02.02 · Cited by 32
Burra, P., Giannini, E. G., Caraceni, P., Corradini, S. G., Rendina, M. G., Volpes, R., & Toniutto, P. (2018) · Liver International · doi:10.1111/liv.13755 · Cited by 33
Myosteatosis predicts survival after surgery for periampullary cancer: a novel method using MRI
van Dijk, D. P. J., Bakers, F. C. H., Sanduleanu, S., Vaes, R. D. W., Rensen, S. S., Dejong, C. H. C., Beets‐Tan, R. G. H., & Damink, S. W. M. O. (2018) · HPB · doi:10.1016/j.hpb.2018.02.378 · Cited by 32
Oshida, N., Shida, T., Oh, S., Kim, T., Isobe, T., Okamoto, Y., Kamimaki, T., Okada, K., Suzuki, H., Ariizumi, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56121-7 · Cited by 32
Clinical impact of sarcopenia assessment in patients with liver cirrhosis
Marasco, G., Dajti, E., Ravaioli, F., Brocchi, S., Rossini, B., Alemanni, L. V., Peta, G., Bartalena, L., Golfieri, R., Festi, D., et al. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1848542 · Cited by 35
Feng, Z., Zhao, H., Kang, W., Liu, Q., Wu, J., Bragazzi, N. L., Ma, X., Wang, W., & Rong, P. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa317 · Cited by 32
Nutrition as Therapy in Liver Disease.
Shah, N., & Barritt, A. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.04.012 · Cited by 24
Ronald, J., Bozdoĝan, E., Zaki, I. H., Kappus, M. R., Choi, S. S., Martin, J. G., Suhocki, P. V., Smith, T. P., Kim, C., & Bashir, M. R. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.19.21655 · Cited by 32
Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease
Majumdar, A., & Tsochatzis, E. A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154291 · Cited by 32
Skladaný, Ľ., Molčan, P., Vnenčáková, J., Vrbová, P., Kukla, M., Lafférs, L., & Koller, T. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/5576531 · Cited by 31
Sarcopenia and Frailty in Cirrhosis
Bunchorntavakul, C. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.12.007 · Cited by 35
Nonalcoholic fatty liver disease and sarcopenia: Where do we stand?
Mikolasevic, I., Pavic, T., Filipec Kanizaj, T., Bender, D. V., Domislovic, V., & Krznaric, Z. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/8859719 · Cited by 30
Current challenges and future perspectives in treating patients with NAFLD-related cirrhosis
Mallet, M., Silaghi, C. A., Sultanik, P., Conti, F., Rudler, M., Ratziu, V., Thabut, D., & Pais, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000456 · Cited by 31
Cespiati, A., Meroni, M., Lombardi, R., Oberti, G., Dongiovanni, P., & Fracanzani, A. L. (2022) · Biomedicines · doi:10.3390/biomedicines10010182 · Cited by 30
Arresting frailty and sarcopenia in cirrhosis: Future prospects
Chen, H., & Dunn, M. A. (2018) · Clinical Liver Disease · doi:10.1002/cld.691 · Cited by 30
Authors, & Collaborators: (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1880-2388 · Cited by 30
Dajti, E., Rodrigues, S. G., Perazza, F., Colecchia, L., Marasco, G., Renzulli, M., Barbara, G., Azzaroli, F., Berzigotti, A., Colecchia, A., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101113 · Cited by 29
Update on Lean Body Mass Diagnostic Assessment in Critical Illness
Rosa, S. D., Umbrello, M., Pelosi, P. P., & Battaglini, D. (2023) · Diagnostics · doi:10.3390/diagnostics13050888 · Cited by 29
Frailty is associated with myosteatosis in obese patients with colorectal cancer
Souza, N. C., González, M. C., Martucci, R. B., Rodrigues, V. D., de Pinho, N. B., de León, A. P., & Avesani, C. M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.02.026 · Cited by 28
Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution
Bellafante, D., Gioia, S., Faccioli, J., Riggio, O., Ridola, L., & Nardelli, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031187 · Cited by 28
Nutritional Challenges in Patients with Advanced Liver Cirrhosis
Stirnimann, J., & Stirnimann, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111926 · Cited by 28
Barazzoni, R., Breda, J., Cuerda, C., Schneider, S. M., Deutz, N. E. P., Wickramasinghe, K. K., Abbasoglu, O., Meijerink, J. B., Bischoff, S., Burgos, R., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.07.033 · Cited by 28
Osteosarcopenia in NAFLD/MAFLD: an underappreciated clinical problem in chronic liver disease
Musio, A., Perazza, F., Leoni, L., Stefanini, B., Dajti, E., Menozzi, R., Petroni, M. L., Colecchia, A., & Ravaioli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087517 · Cited by 26
Zou, W. Y., Enchakalody, B. E., Zhang, P., Shah, N. V., Saini, S. D., Wang, N. C., Wang, S. C., & Su, G. L. (2021) · Hepatology Communications · doi:10.1002/hep4.1768 · Cited by 28
Dhariwal, S., Roy, A., Taneja, S., Bansal, A., Gorsi, U., Singh, S., De, A., Verma, N., Premkumar, M., Duseja, A. K., et al. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001745 · Cited by 27
Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease
Chun, H. S., Lee, M., Lee, H. A., Lee, S., Kim, S.-Y., Jung, Y. J., Lee, C., Kim, H., Lee, H. A., Kim, H. Y., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.11.031 · Cited by 29
Hepatic encephalopathy – recent advances in treatment and diagnosis
Nardelli, S., Gioia, S., Faccioli, J., Riggio, O., & Ridola, L. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2183386 · Cited by 27
The association of testosterone with sarcopenia and frailty in chronic liver disease
Chrysavgis, L., Adamantou, M., Angelousi, A. G., & Cholongitas, Ε. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14108 · Cited by 28
Ishida, J., Saitoh, M., Doehner, W., von Haehling, S., Anker, M. S., Anker, S. D., & Springer, J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.154 · Cited by 27
Elsheikh, M., Sabagh, A. E., Mohamed, I. B., Bhongade, M., Hassan, M. M., & Jalal, P. K. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i46.6028 · Cited by 28
Nutrition in Patients With Cirrhosis.
Calmet, F. H., Martin, P. B., & Pearlman, M. Y. (2019) · PubMed Central · Cited by 26
Vedder, I. R., Levolger, S., Dierckx, R., Zeebregts, C. J., de Vries, J. P. P. M., Viddeleer, A. R., & Bokkers, R. P. H. (2020) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2020.03.050 · Cited by 26
Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy
Cola, S. D., Nardelli, S., Ridola, L., Gioia, S., Riggio, O., & Merli, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030611 · Cited by 26
Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies
Fox, R., Stenning, K., Slee, A., Macnaughtan, J., & Davies, N. A. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2022.114581 · Cited by 27
Chang, K. C., Chen, J.-D., Wu, W., Huang, K., & Han, D. (2019) · Medicine · doi:10.1097/md.0000000000014373 · Cited by 26
Update on the Complications and Management of Liver Cirrhosis
Fadlallah, H., Masri, D. E., Bahmad, H. F., Abou-Kheir, W. G., & Masri, J. E. (2025) · Medical Sciences · doi:10.3390/medsci13010013 · Cited by 37
Systematic review with meta‐analysis: Nutritional screening and assessment tools in cirrhosis
Ney, M. S., Li, S., Vandermeer, B., Gramlich, L. M., Ismond, K. P., Raman, M., & Tandon, P. (2019) · Liver International · doi:10.1111/liv.14269 · Cited by 26
Meister, F., Bednarsch, J., Amygdalos, I., Boecker, J., Strnad, P., Bruners, P., Lang, S. A., Ulmer, T. F., Heij, L. R., Santana, D. A. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92798-5 · Cited by 25
Jing, X., Tan, L., Fu, H., Yang, L. Y., & Yang, M. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.743698 · Cited by 26
Geladari, E. V., Alexopoulos, T., Kontogianni, M. D., Vasilieva, L., Mani, I., Τέντα, Ρ., Sevastianos, V., Vlachogiannakos, J., & Alexopoulou, A. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093332 · Cited by 28
Shi, S., Zhao, Y., Fan, J.-L., Chang, L.-Y., & Yu, D. (2023) · Academic Radiology · doi:10.1016/j.acra.2023.05.022 · Cited by 25
Feng, Z., Zhao, H., Jiang, Y., He, Z., Sun, X., Rong, P., & Wang, W. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.01.021 · Cited by 26
Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis
Kusnik, A. T., Penmetsa, A., Chaudhary, F., Renjith, K., Ramaraju, G. A., Laryea, M. A., & Allard, J. P. (2024) · Gastroenterology Research · doi:10.14740/gr1707 · Cited by 27
Feng, Z., Rong, P., Luo, M., Sun, X., & Wang, W. (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1519 · Cited by 23
Myosteatosis in nonalcoholic fatty liver disease: An exploratory study
Munck, T. J. I. D., Verhaegh, P. L. M., Lodewick, T. M., Bakers, F. C. H., Jonkers, D. M. A. E., Masclee, A., Verbeek, J., & Koek, G. H. (2020) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2020.06.021 · Cited by 24
Bot, D., Droop, A., Lucassen, C. J., van Veen, M. E., van Vugt, J. L. A., Feshtali, S., Leistra, E., Tushuizen, M. E., & van Hoek, B. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.01.022 · Cited by 24
Metadata
- Authors
- Montano-Loza, A. J., Angulo, P., Meza-Junco, J., Prado, C. M. M., Sawyer, M. B., Beaumont, C., Esfandiari, N., Ma, M., & Baracos, V. E.
- Affiliations
- Division of Gastroenterology & Liver Unit; University of Alberta Hospital; Edmonton Alberta Canada
- University of Kentucky HealthCare (US)
- Department of Oncology; Cross Cancer Institute; Edmonton Alberta Canada
- University of Alberta (CA)
- Cross Cancer Institute (CA)
- Alberta Hospital Edmonton (CA)
- Venue
- Journal of Cachexia Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2015-06-09
- Volume
- 7
- Issue
- 2
- Pages
- 126-135
- ISSN
- 2190-5991 (ISSN-L)
- PMC
- PMC4864157
- OpenAlex
- W1490232555
- Cited by
- 512
- References
- 43
- Citations by year
- 2026: 29 · 2025: 34 · 2024: 67 · 2023: 67 · 2022: 78 · 2021: 53 · 2020: 48 · 2019: 53 · 2018: 48 · 2017: 26 · 2016: 4 · 2015: 3
- FWCI
- 19.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Cachexia Sarcopenia and Muscle (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by-nc-nd)
- Funders
- American College of Gastroenterology Institute 2011
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- myosteatosis, sarcopenia, liver cirrhosis, mortality, skeletal muscle, hepatic steatosis, prognostic factors, hepatitis C, alcoholic cirrhosis, nonalcoholic steatohepatitis, autoimmune liver disease, hepatitis B, body mass index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
